Hyderabad-based pharmaceutical firm Laurus Labs has received in-principle approval from the United States Food and Drugs Administrator (FDA) to launch the world’s first Oral Dispersible...
Continue ReadingBiocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, announced that it has won the prestigious ‘Bioprocessing Excellence in South Asia’ Award at the Asia-Pacific...
Continue ReadingPharmaceuticals firm Lupin Ltd. said it has received tentative approval from the U.S. health regulator to market its generic valbenazine capsules used to treat involuntary...
Continue ReadingThe construction of the state-of-the-art 300-bedded oncology block developed at a cost of Rs 80 crore in State-run MNJ Cancer Hospital campus by Aurobindo Pharma...
Continue ReadingGlobal Fund, USAID and Stop TB Partnership entered into a collaboration with Goa-based Molbio Diagnostics, India’s leading point-of-care molecular diagnostics company and inventor of the...
Continue ReadingAurobindo Pharma Foundation (APF), the philanthropic arm of Aurobindo Pharma Ltd, has inaugurated and dedicated Vedasadanam Block to Sankara Gurukula Veda Patasala located in Shameerpet,...
Continue ReadingDrug firm Lupin said it has received approval from the US health regulator for Brexpiprazole tablets used to treat certain mental and mood disorders.The approval...
Continue ReadingCipla Ltd, and its wholly owned subsidiaries, Cipla (EU) Limited, and Meditab Holdings Limited, have signed a Share Purchase Agreement with Africa Capitalworks SSA 3...
Continue ReadingDrugmaker Aurobindo Pharma’s subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market cancer...
Continue Reading